This Viewpoint discusses the uncertain prognostic value of testing for Alzheimer disease biomarkers in asymptomatic individuals and warns of the possible insurance, employment, financial, and psychological repercussions of positive results of such tests.
No takes yet. Share an insight, caveat, or question.
Gayatri Devi (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: